Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...

Rhythm Biosciences has upgraded its geneType colorectal cancer test with additional lifestyle and clinical risk factors. ...

We existed in our own world that day, absorbing information we never wanted to learn. At one point, while I was crying ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

North Lamar High School HOSA students recently presented a $2,858 donation to the Paris Lamar County Health District to ...

There's a new addition in Barrio Centenario, Darío Sarmiento successfully passed the medical examination conducted this ...

U.S. cancer survival rates have reached an all-time high, yet a 2026 American Cancer Society report shows disparities in ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

Doctors say disruptions in cancer screening tend to compound over time and could lead to higher mortality rates.

Beyond smart watches and rings, artificial intelligence is being used to make self-testing for major diseases more readily ...

While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...